Peter Powchik is SVP Clinical Development & Reg at REGENERON PHARMACEUTICALS INC (REGN). They have made 2 open-market trades across 1 company since 2011, most recently 2016-05-16.
CIK 0001377247
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 2,459 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2016-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | SELL | 2015-08-14 | 2015-08-17 | $573.38 | $13.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2015-01-02 | 2015-01-05 | $414.08 | $4.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2014-01-02 | 2014-01-03 | $274.77 | $5.7M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2013-12-18 | 2013-12-20 | $270.21 | $2.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2013-12-17 | 2013-12-17 | $270.00 | $2K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2013-01-03 | 2013-01-04 | $182.11 | $2.5M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-12-19 | 2012-12-20 | $175.43 | $3.0M | -13.6% | -2.9% | -2.9% |
| REGN | SELL | 2012-11-08 | 2012-11-09 | $138.62 | $2.1M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-09-19 | 2012-09-20 | $147.17 | $1.1M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-07-26 | 2012-07-27 | $130.64 | $917K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2012-02-22 | 2012-02-23 | $96.34 | $4.7M | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2011-07-26 | 2011-07-26 | $54.89 | $602K | -13.6% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.